Year archive

Jacobio Pharmaceuticals Group Co., Ltd. — 2025 filings

All 64 regulatory filings released by Jacobio Pharmaceuticals Group Co., Ltd. (1167) in 2025, sourced directly from the official regulator.

64 Filings

2025 Period

2025 filings (64)

Filing	Released	Lang
INSIDE INFORMATION LICENCE AND COLLABORATION AGREEMENT WITH ASTRAZENECA FOR PAN-KRAS INHIBITOR JAB-23E73 M&A Activity	2025-12-21	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2025 Transaction in Own Shares	2025-12-03	English
VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED UPFRONT PAYMENT UPON THE CAPITAL INCREASE AGREEMENT AND EQUITY TRANSFER AGREEMENT Capital/Financing Update	2025-12-02	English
VOLUNTARY ANNOUNCEMENT JACOBIO'S KRAS G12C AND SHP2 COMBINATION THERAPY PUBLISHED IN THE LANCET RESPIRATORY MEDICINE Regulatory Filings	2025-12-01	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-13	English
APPOINTMENT OF CO-CHIEF EXECUTIVE OFFICER Board/Management Information	2025-11-12	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-12	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-11	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-07	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-06	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025 Transaction in Own Shares	2025-11-05	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-11-03	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-30	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-30	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-24	English
VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTED PRECLINICAL DATA OF PAN-KRAS INHIBITOR JAB-23E73 AT THE AACR-NCI-EORTC 2025 INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS Regulatory Filings	2025-10-24	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-23	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-22	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-20	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-10-17	English
VOLUNTARY ANNOUNCEMENT ENTERING INTO THE CAPITAL INCREASE AGREEMENT AND EQUITY TRANSFER AGREEMENT Capital/Financing Update	2025-10-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025 Regulatory Filings	2025-10-06	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-29	English
VOLUNTARY ANNOUNCEMENT CHANGE IN SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT AND UPDATES ON ON-MARKET SHARE REPURCHASE BY THE COMPANY Transaction in Own Shares	2025-09-26	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-09-25	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-09-24	English
VOLUNTARY ANNOUNCEMENT FURTHER INCREASE SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT Major Shareholding Notification	2025-09-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2025 Regulatory Filings	2025-09-03	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE Governance Information	2025-08-29	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-29	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025 Regulatory Filings	2025-08-04	English
VOLUNTARY ANNOUNCEMENT FURTHER INCREASE SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT Major Shareholding Notification	2025-07-30	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-07-28	English
VOLUNTARY ANNOUNCEMENT FURTHER INCREASE SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT Major Shareholding Notification	2025-07-24	English
VOLUNTARY ANNOUNCEMENT INCREASE SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT Major Shareholding Notification	2025-07-21	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-07-15	English
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2025-07-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025 Regulatory Filings	2025-07-03	English
VOLUNTARY ANNOUNCEMENT JACOBIO COMPLETED THE FIRST PATIENT DOSAGE IN THE PHASE I/IIA CLINICAL TRIAL OF PAN-KRAS INHIBITOR JAB-23E73 IN U.S. Regulatory Filings	2025-07-02	English
SEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2025-06-10	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025 Share Issue/Capital Change	2025-06-03	English
INSIDE INFORMATION - JACOBIO'S KRAS G12C INHIBITOR GLECIRASIB APPROVED FOR MARKET LAUNCH Regulatory Filings	2025-05-22	English
FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-14	English
NOTICE OF 2025 ANNUAL GENERAL MEETING AGM Information	2025-05-14	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL G Proxy Solicitation & Information Statement	2025-05-14	English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2025-05-09	English
VOLUNTARY ANNOUNCEMENT SHP2 INHIBITOR SITNEPROTAFIB COMBINATION THERAPY DATA PUBLISHED IN ACADEMIC JOURNAL Regulatory Filings	2025-05-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025 Regulatory Filings	2025-05-06	English
VOLUNTARY ANNOUNCEMENT CHANGES IN THE INTERESTS OF THE PARTIES ACTING IN CONCERT Major Shareholding Notification	2025-04-30	English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Report Publication Announcement	2025-04-25	English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2025-04-25	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-24	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2025-04-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025 Regulatory Filings	2025-04-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-03-19	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024; CHANGE IN USE OF PROCEEDS; AND CHANGE IN THE COMPOSITION OF THE NOMINATION COMMITTEE Earnings Release FY 2024	2025-03-19	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2025 Regulatory Filings	2025-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2025 Share Issue/Capital Change	2025-02-05	English
VOLUNTARY ANNOUNCEMENT THE REGISTRATIONAL CLINICAL DATA OF KRAS INHIBITOR GLECIRASIB WAS PUBLISHED IN THE MEDICAL JOURNAL NATURE MEDICINE Regulatory Filings	2025-01-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2024 Regulatory Filings	2025-01-06	English